# Bioventus Inc.: Form 8-K, filed Aug 4, 2025

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 4, 2025, 08:15 ET
- Period: 2025-07-31
- Accession: 0001193125-25-172192
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000119312525172192/d865758d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000119312525172192/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000119312525172192/d865758d8k.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-172192. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.